• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Obstetrics

ADHD medications in pregnancy may increase risk of infantile morbidity

byKate AndersonandCordelia Ross
November 10, 2017
in Obstetrics, Pediatrics, Psychiatry
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Infants born to mothers who used medications for treatment of attention-deficit/hyperactivity disorder (ADHD) during pregnancy had increased risk of central nervous system (CNS) disorders, prematurity, and admission to the neonatal intensive care unit (NICU).

2. ADHD medication use during pregnancy was not associated with increased risk of neonatal mortality or congenital malformations.

Evidence Level: 2 (Good)

Study Rundown: In the United States, ADHD medications, including stimulants and atomoxetine, are used by approximately 1% of women during pregnancy. Despite being one of the most frequently prescribed medications among pregnant women, little evidence exists on the effect of antepartum stimulant use on perinatal outcomes. Authors of this study compared neonatal morbidity and mortality among infants born to mothers who either used their ADHD medications during pregnancy or did not use ADHD medications, as well as to mothers who were exposed only before and after pregnancy. Results showed neonates whose mothers continued medication use during pregnancy had higher rates of NICU admission and CNS disorders, compared to infants in the other 2 groups. These rates were similar even after excluding mothers who used atomoxetine (non-stimulant) only. Antepartum maternal ADHD medication use also increased risk of prematurity and being large for gestational age, compared to neonates whose mothers had no medication use. One limitation of this study is the potential of confounding from other factors that were significantly higher among women who continued ADHD medication use during pregnancy, including use of other psychoactive prescription medications, younger age, smoking, and obesity. Nonetheless, the findings from this study should be considered by psychiatrists and other physicians managing ADHD medications among pregnant women.

Click to read the study, published today in Pediatrics

Relevant reading: Increasing use of ADHD medications in pregnancy

In-depth [retrospective cohort]: Participants in this study included live singleton births that occurred in Sweden between 2006 and 2014. Using several data registries, researchers collected data on maternal demographics, pregnancy course, and drug use, as well as data on perinatal outcomes from 964,734 births (1591 ADHD medications during pregnancy, 9475 medications before or after pregnancy, and 953,668 no medication use). Results showed that exposure to ADHD medications (both stimulants and atomexitine) during pregnancy was associated with higher rates of NICU admission (aOR 1.5, 95% CI 1.3-1.7 and aOR 1.2, 95% CI 1.1-1.4 for no medication use and use before or after pregnancy, respectively) and of neonatal CNS disorders (aOR 1.9, 95% CI 1.1-3.1 and aOR 1.8, 95% CI 1.0-3.3 for no medication use and medication use before or after pregnancy, respectively). These rates were similar even after excluding mothers whose used atomoxetine rather than a stimulant medication. Overall, 1.0% of neonates with in utero exposure to ADHD medication (N=16), 0.4% whose mothers used medication before or after pregnancy (N=40) and 0.3% with no ADHD medication exposure (n=2885) experienced CNS-related disorders. Neonates exposed to these medications in utero also showed higher rates of moderately preterm birth and large for gestational age compared to neonates not exposed to these medications (aOR 1.3 (95% CI 1.1–1.6 and aOR 1.3 95% CI, 1.0–1.7, respectively). There was no significant difference in neonatal mortality or frequency of congenital malformations among the groups. Of note, mothers who used ADHD medications during pregnancy differed significantly from mothers who had no ADHD medication use in several ways: they were more likely to be younger, obese, smokers and to have used other neurotropic drugs during pregnancy.

RELATED REPORTS

Noninvasive ventilation with neurally adjusted ventilatory assist (NIV-NAVA) outperforms nasal continuous positive airway pressure (NCPAP) post-extubation in preterm infants

Antenatal corticosteroids may affect neurodevelopment differently based on gestational age

Presence of second midwife during the second active stage of labour reduces the risk of severe perineal trauma

Image: CC

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: ADHDneonatologypregnancy complicationspremature infantstimulants
Previous Post

Anti-TNF agents and thiopurines are associated with a slight increase in lymphoma in IBD patients

Next Post

Rising price of health services drove increase in US health care spending

RelatedReports

No decrease in infant mortality with maternal micronutrient supplementation in Bangladesh
Pediatrics

Noninvasive ventilation with neurally adjusted ventilatory assist (NIV-NAVA) outperforms nasal continuous positive airway pressure (NCPAP) post-extubation in preterm infants

May 6, 2022
Abusive head trauma results in fewer productive life-years
Chronic Disease

Antenatal corticosteroids may affect neurodevelopment differently based on gestational age

April 28, 2022
Women electing abortion more likely to be victims of domestic violence
Chronic Disease

Presence of second midwife during the second active stage of labour reduces the risk of severe perineal trauma

April 7, 2022
Oophorectomy associated with reduced cancer risk and all-cause mortality for BRCA1/2 patients
Genetics

Rapid genotyping for variant associated with aminoglycoside-induced ototoxicity is feasible in acute neonatal setting

April 6, 2022
Next Post
HOSPITAL score predicts risk of 30-day potentially avoidable readmission to hospital

Rising price of health services drove increase in US health care spending

Child maltreatment associated with poor adult socioeconomic status

Influenza vaccine administered to all pediatric emergency department patients may be cost-effective

Adverse pregnancy outcomes associated with thrombophilias [Classics Series]

The DOSE trial: Loop diuretic strategies in acute decompensated heart failure [Classics Series]

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Severe actinic keratosis and need for additional treatment are markers for an increased risk of cutaneous squamous cell carcinoma
  • Virtual yoga and meditation intervention may be associated with increased health-related quality of life
  • Wellness Check: Mental Health
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.